Melissa Tuck

Medicine · Health Sciences

11h-index2.5kcitations20works20.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(7), Monoclonal and Polyclonal Antibodies Research(5), Cancer Genomics and Diagnostics(3), Radiopharmaceutical Chemistry and Applications(3), Advanced Proteomics Techniques and Applications(2)

Publications20 total

ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancer
JCI Insight·2024· 20 citedOpen Access
Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in <i>BCAT1</i> and <i>IKZF1</i>
Cancer·2022· 18 cited
Evaluation of Circulating Tumor DNA for Methylated <i>BCAT1</i> and <i>IKZF1</i> to Detect Recurrence of Stage II/Stage III Colorectal Cancer (CRC)
Cancer Epidemiology Biomarkers & Prevention·2020· 32 citedOpen Access
Contributors
Elsevier eBooks·2019
A Blood-Based Marker Panel for Detection of Colorectal Neoplasia
Gastroenterology·2017· 1 cited
List of Contributors
Elsevier eBooks·2013
Serum and Plasma Collection
Elsevier eBooks·2013· 5 cited
Serum and plasma collection: Preanalytical variables and standard operating procedures in biomarker research
Elsevier eBooks·2013· 2 cited
Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: Comparison to fecal occult stool blood test
Cancer Biomarkers·2011· 1 citedOpen Access
Abstract 1286: Pharmacodynamics of oral curcumin in plasma and rectal mucosa in a Phase IIa trial
Cancer Research·2011
Abstract 2906: Curcumin reduces aberrant crypt foci (ACF) number but does not alter prostaglandin E2 (PGE2) or 5-hydroxyeicosanopentaneic acid (5-HETE) concentration in ACF or in normal human colorectal mucosa
Cancer Research·2010
Tositumomab and Iodine I-131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma: Median 10 Year Follow-up Results.
Blood·2009· 25 cited
Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement <i>Standard Operating Procedure Integration Working Group</i>
Journal of Proteome Research·2008· 714 citedOpen Access
I131-tositumomab monotherapy as frontline treatment for follicular lymphoma: Updated results after a median follow-up of 8 years
Journal of Clinical Oncology·2007· 14 cited
<sup>131</sup>I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma
New England Journal of Medicine·2005· 714 citedOpen Access
Radioimmunotherapy with Iodine-131 Tositumomab in Patients with Low-Grade Non-Hodgkin's B-Cell Lymphoma Does Not Induce Loss of Acquired Humoral Immunity against Common Antigens
Clinical Immunology·2001· 11 cited
Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience
Blood·2000· 26 citedOpen Access
Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience
Blood·2000· 521 cited
Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma.
Journal of Clinical Oncology·1996· 401 cited
Effect of Interleukin-l?? on the In Vitro Activation of Tumor-Draining Lymph Node Cells for Adoptive Immunotherapy
Journal of Immunotherapy·1994· 2 cited

Frequent Co-authors

Dean E. Brenner(9), Mark Kaminski(7), Judith Estes(6), Richard L. Wahl(6), Denise Regan(5), D. Kim Turgeon(5), Charles W. Ross(4), Kenneth Zasadny(4), Susan J. Fisher(4), Arne Kolstad(3), Stewart Kroll(3), Isaac R. Francis(3), Jeanne Gutierrez(2), Robert Stagg(2), George F. Tidmarsh(2), C. W. Ross(2), Benjamin Musher(2), Susanne K. Pedersen(2), Lawrence C. LaPointe(2), Graeme P. Young(2)